313 related articles for article (PubMed ID: 1309865)
21. Therapeutic efficacy of combined meso 2,3-dimercaptosuccinic acid and calcium disodium edetate treatment during acute lead intoxication in rats.
Flora GJ; Seth PK; Prakash AO; Mathur R
Hum Exp Toxicol; 1995 May; 14(5):410-3. PubMed ID: 7612302
[TBL] [Abstract][Full Text] [Related]
22. Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats.
Flora SJ; Bhattacharya R; Vijayaraghavan R
Fundam Appl Toxicol; 1995 May; 25(2):233-40. PubMed ID: 7665007
[TBL] [Abstract][Full Text] [Related]
23. Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.
Meldrum JB; Ko KW
Am J Vet Res; 2003 Jun; 64(6):672-6. PubMed ID: 12828250
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication.
Flora SJ; Pande M; Mehta A
Chem Biol Interact; 2003 Jun; 145(3):267-80. PubMed ID: 12732454
[TBL] [Abstract][Full Text] [Related]
25. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
Schwartz BS; Lee BK; Stewart W; Sithisarankul P; Strickland PT; Ahn KD; Kelsey K
Occup Environ Med; 1997 Apr; 54(4):241-6. PubMed ID: 9166129
[TBL] [Abstract][Full Text] [Related]
26. Meso-2,3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers.
Restek-Samarzija N; Blanusa M; Pizent A; Samarzija M; Turk R; Corović N; Jurasović J
Arh Hig Rada Toksikol; 1998 Jun; 49(2):137-45. PubMed ID: 9919719
[TBL] [Abstract][Full Text] [Related]
27. Disappearance of heme metabolites following chelation therapy with meso 2,3-dimercaptosuccinic acid (DMSA).
Tutunji MF; al-Mahasneh QM
J Toxicol Clin Toxicol; 1994; 32(3):267-76. PubMed ID: 8007034
[TBL] [Abstract][Full Text] [Related]
28. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
Glotzer DE
Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
[TBL] [Abstract][Full Text] [Related]
29. CaEDTA vs CaEDTA plus BAL to treat children with elevated blood lead levels.
O'Connor ME
Clin Pediatr (Phila); 1992 Jul; 31(7):386-90. PubMed ID: 1617861
[TBL] [Abstract][Full Text] [Related]
30. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
31. Lead poisoning and chelation in a mother-neonate pair.
Horowitz BZ; Mirkin DB
J Toxicol Clin Toxicol; 2001; 39(7):727-31. PubMed ID: 11778671
[TBL] [Abstract][Full Text] [Related]
32. Management of Lead Encephalopathy with DMSA After Exposure to Lead-Contaminated Moonshine.
Arnold J; Morgan B
J Med Toxicol; 2015 Dec; 11(4):464-7. PubMed ID: 26245877
[TBL] [Abstract][Full Text] [Related]
33. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
[TBL] [Abstract][Full Text] [Related]
34. Effects of combined administration of calcium, iron, zinc, chrysanthemum flavonoids, and DMSA on the treatment of lead intoxication in mice.
Huali T; Honglei P; Feng W; Shaokang W; Ligang Y; Jianghong L; Guiju S
J Biochem Mol Toxicol; 2020 Feb; 34(2):e22425. PubMed ID: 31729815
[TBL] [Abstract][Full Text] [Related]
35. Combined administration of taurine and meso 2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats.
Flora SJ; Pande M; Bhadauria S; Kannan GM
Hum Exp Toxicol; 2004 Apr; 23(4):157-66. PubMed ID: 15171566
[TBL] [Abstract][Full Text] [Related]
36. Reversing the adverse biochemical effects in lead-intoxicated rats by N,N`- bis[(1,2-didehydro-1-hydroxy-2-thioxopyrid-4-yl)-carbonyl]- L-lysine.
Ata SA; Abu-Dari KI; Tutunji MF; Mubarak MS
J Trace Elem Med Biol; 2018 Dec; 50():93-99. PubMed ID: 30262322
[TBL] [Abstract][Full Text] [Related]
37. Lead, zinc, and erythrocyte delta-aminolevulinic acid dehydratase: relationships in lead toxicity.
Thomasino JA; Zuroweste E; Brooks SM; Petering HG; Lerner SI; Finelli VN
Arch Environ Health; 1977; 32(6):244-7. PubMed ID: 412470
[TBL] [Abstract][Full Text] [Related]
38. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
40. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
